Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

American Spectrum Realty FY11 FFO Rises

American Spectrum Realty Inc. (AQQ: Quote), a real estate investment, management and leasing company, Friday reported full-year 2011 net income attributable to common stockholders of $3.8 million or $1.32 per share, compared to $8.3 million or $2.76 per share last year.

Full-year 2011 net income included income from discontinued operations of $17.3 million, compared to a loss from discontinued operations of $0.8 million last year.

Funds from operations, or FFO, for the year was $2.1 million compared to a negative FFO of $4.1 million last year. The increase due mainly to a gain recognized on litigation settlement.

Total revenues grew to $69.4 million from $49.2 million last year.

Click here to receive FREE breaking news email alerts for American Spectrum Realty Inc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
After moving modestly higher in morning trading, stocks showed a substantial move to the downside over the course of the trading day on Wednesday. The major averages pulled back well off their highs for the session, sliding firmly into negative territory. Ebola "czar" Ron Kain is scheduled to meet with President Barack Obama on Wednesday as he begins his efforts to coordinate the government's response to the deadly disease. Klain, who previously served as chief of staff to Vice President Joe Biden and then-Vice President Al Gore, was named as Ebola Response Coordinator last Friday. Potentially complicating the outlook for control of the Senate, the results of a SurveyUSA poll conducted for WXIA-TV in Atlanta suggest that the Georgia Senate race between Republican David Perdue and Democrat Michelle Nunn could be headed for a runoff.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.